切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - DREADD Ligands - COX - Topoisomerases - adrenergic receptor

36件产品中的 1-10

页面
每页
清除全部
  1. (S)-10-Hydroxycamptothecin
    B4745 (S)-10-Hydroxycamptothecin
    中文名: 羟喜树碱
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.8 mg/mL
      insoluble in H2O
  2. Ellipticine
    B7382 Ellipticine
    中文名: 玫瑰树碱,椭圆玫瑰树碱
    Target: Topoisomerases
    Summary: DNA拓扑异构酶II抑制剂
      ≥24.6 mg/mL
      insoluble in H2O
  3. Epinephrine Bitartrate
    B1358 Epinephrine Bitartrate
    中文名: 酒石酸肾上腺素
    Target: adrenergic receptor
    Summary: 肾上腺素能受体激动剂
      ≥16.66 mg/mL
      ≥22.9 mg/mL
  4. Pirarubicin
    B2295 Pirarubicin
     1 Citation
    中文名: 吡柔比星
    Target: Topoisomerases
    Summary: 拓扑异构酶II抑制剂,蒽环类抗生素
      ≥7.65 mg/mL
      insoluble in H2O
  5. Latrepirdine
    B1572 Latrepirdine
    Target: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptor
    Summary: 脑细胞死亡抑制剂
      ≥19.62 mg/mL
      insoluble in H2O
  6. Flunixin Meglumin
    B1445 Flunixin Meglumin
    中文名: 氟尼辛葡甲胺
    Target: COX
    Summary: 环氧合酶抑制剂
      ≥24.55 mg/mL
      ≥23.2 mg/mL
  7. Lornoxicam
    B1441 Lornoxicam
    中文名: 氯诺昔康
    Target: COX
    Summary: COX-1/COX-2抑制剂
      ≥18.59 mg/mL
      insoluble in H2O
  8. Lumiracoxib
    B1458 Lumiracoxib
    中文名: 罗美昔布
    Target: COX
    Summary: 新型的选择性COX-2抑制剂
      ≥29.4 mg/mL
      insoluble in H2O
  9. Suprofen
    B2133 Suprofen
    中文名: 舒洛芬
    Target: COX
    Summary: 双重COX-1/COX-2抑制剂
      ≥82.8 mg/mL
      insoluble in H2O
  10. Antipyrine
    B1886 Antipyrine
    中文名: 安替比林
    Target: COX
    Summary: 止痛药和解热药
      ≥5.5 mg/mL
      ≥66.3 mg/mL

36件产品中的 1-10

页面
每页